Leprosy Mailing List – January 15, 2017
Ref.: (LML) Indian Leprosy Vaccine
From: Eric Wan, Maryland, USA
Dear Dr. Schreuder and LML,
I recently read on the news about a vaccine trial on-going in India. I recall Dr. Grace Warren's September 18 2016 LML post in which she inquired for more information. I am a young researcher fairly new to the field and would like to learn more about the history and science of this vaccine. Will anyone be able to help give a complete timeline and bibliography / references?
In my pursuit of knowledge, I asked the United States Food and Drug Administration but they and our National Cancer Institute told me they don't have any information on the vaccine marketed as mycobacterium pranii (MiP) or IMMUVAC. They only have information on approved drugs, so perhaps it's in the works?
Many thanks,
Eric
--
Eric Lee Wan, BS
Consultant (Community Health & Research)
Fundación Padre Damian
Guayaquil, Ecuador
+593 4-228-6649
Research Affiliate
Department of Plastic and Reconstructive Surgery,
Johns Hopkins University School of Medicine
Baltimore, Maryland, USA
Google Voice: +1 (678) 744-9361
USA Cell: +1 (240) 899-1181
Ecuador Cell: +593 (96) 804-5383
Colombia Cell: +57 (313) 780-6653
Skype: ericleewan
https://www.linkedin.com/in/ericleewan
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
 | This email has been checked for viruses by Avast antivirus software. |
No comments:
Post a Comment